NCT00460005已完成不适用
A Multicenter Study to Determine the Clinical Characteristics of the Temporal Aspects of Migraine in a Canadian Population: Clinical Study Of Migraine Evolution (C-SOME)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 250
- 试验地点
- 1
研究概览
简要总结
Understanding the speed at which migraine headaches develop is of importance to patients. Determining the proportions in which different headache pain build-up occurs, may provide health care practitioners with valuable information with which to prescribe the most appropriate treatment. Patients who experience a slow pain build-up may gain more benefit from medications which have a slow onset of effect, high tolerability and long action. Conversely, medications with a rapid onset of effect may be of greater benefit to patients who experience rapid onset of migraine pain.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject is outpatient.
- •Subject has a diagnosis of migraine with/without aura according to IHS criteria, of at least 1 years duration.
- •Subject is able to comprehend the study procedures and to comply with study requirements.
排除标准
- •Subject has other chronic pain condition(s) not associated with migraine
- •Subject is unable to understand the schedule/questionnaire.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic MigraineChronic MigraineNCT05216263AbbVie75
已完成
不适用
An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult ParticipantsMigraineNCT05653986AbbVie391
Unknown
3 期
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)MigraineNCT05127954AbbVie1,200
已完成
4 期
Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With MigraineEpisodic MigraineNCT05264129AbbVie263
招募中
不适用
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic MigraineChronic MigraineEpisodic MigraineMigraineNCT06603558AbbVie3,000
